NORRIS PERNE & FRENCH LLP/MI – Bristol-Myers Squibb Company Transaction History
NORRIS PERNE & FRENCH LLP/MI portfolio value:
$512,000
portfolio value
NORRIS PERNE & FRENCH LLP/MI quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -97.36% | -265.62K shares | -20.49M | $71.09 | 7.20K |
| Q2 2022 | share | Decrease | -2.92% | -8.20K shares | 484K | $77 | 272.83K |
| Q1 2022 | share | Increase | +0.05% | 145 shares | 3.01M | $73.03 | 281.03K |
| Q4 2021 | share | Increase | +0.92% | 2.56K shares | 1.04M | $62.52 | 280.88K |
| Q3 2021 | share | Increase | +2.04% | 5.55K shares | -1.75M | $59.17 | 278.32K |
| Q2 2021 | share | Increase | +1.71% | 4.59K shares | 1.29M | $65.79 | 272.76K |
| Q1 2021 | share | Increase | +13.35% | 31.58K shares | 2.25M | $62.15 | 268.17K |
| Q4 2020 | share | Increase | +3.23% | 7.40K shares | 858K | $60.6 | 236.59K |
| Q3 2020 | share | Increase | +2.71% | 6.04K shares | 697K | $58 | 229.18K |
| Q2 2020 | share | Increase | +1.60% | 3.52K shares | 879K | $56.14 | 223.14K |
| Q1 2020 | share | Increase | +19.74% | 36.20K shares | 469K | $52.79 | 219.62K |
| Q4 2019 | share | Increase | +2.72% | 4.85K shares | 2.71M | $60.36 | 183.41K |
| Q3 2019 | share | Increase | 0.00% | 178.55K shares | 9.05M | $47.3 | 178.55K |